A randomized controlled trial to evaluate outcomes with Aggrenox in patients with SARS-CoV-2 infection is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: UL1TR003017
National Institutes of Health
Grant: NS065957 and NS103740
NINDS NIH HHS
Grant: R01 NS061844
Boehringer Ingelheim
MeSH Terms